Clinical Trial Update: Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study evaluating neurocognitive function changes associated with extended-release tacrolimus in older kidney tran…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Tacrolimus extended-release (Tacrolimus)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Kidney Transplant Recipients, Old Age | Phase 4 | Status: RECRUITING